Results for tag: "Uveal Melanoma Drug"

Uveal Melanoma is a rare form of cancer that affects the eye. It is the most common primary intraocular malignancy in adults. Treatment for Uveal Melanoma is typically systemic chemotherapy, radiation therapy, or a combination of both. Oncology drugs are used to treat Uveal Melanoma, and the Uveal Melanoma Drug market is a subset of the larger Oncology Drug market. The Uveal Melanoma Drug market is composed of a variety of drugs, including targeted therapies, immunotherapies, and chemotherapy. These drugs are used to treat Uveal Melanoma, and they are designed to target the specific genetic mutations that cause the cancer. The drugs are designed to be more effective and less toxic than traditional chemotherapy drugs. The Uveal Melanoma Drug market is a rapidly growing market, as new drugs are being developed to treat this rare form of cancer. Companies in the market include Novartis, Merck, Bristol-Myers Squibb, Roche, and Pfizer. Show Less Read more